Kyivstar Selects Mavenir to Deliver Enhanced Enterprise Fixed-Mobile Convergence Services 24-02-2025, 14:00

Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody 12-12-2024, 04:35

BlueCat announces new capabilities to help organizations modernize their network infrastructure 27-03-2024, 21:30